BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11503502)

  • 21. Transposition of the Blood Directive into national law--the perspective of Portugal.
    Gonçalves MH; Muon MC; Gonçalves Jd
    Transfus Clin Biol; 2005 Feb; 12(1):18-20. PubMed ID: 15814287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Blood transfusion safety: current progress].
    Boyez E; Malherbe P; Tiry-Lescut C; Fontaine O
    Ann Biol Clin (Paris); 2004; 62(4):462-4. PubMed ID: 15297243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Labile blood products and their preparation].
    Chabanel A; Folléa G
    Rev Prat; 2001 Jun; 51(12):1306-10. PubMed ID: 11503503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The pretransfusion bedside agglutination test is not a "Gold Standard"].
    Levy G
    Transfus Clin Biol; 2008 Nov; 15(5):318-21. PubMed ID: 18930684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innovations in blood donor screening and blood collection.
    Smith JW; Forsberg JE; Gilcher RO
    Curr Hematol Rep; 2002 Nov; 1(2):129-33. PubMed ID: 12901134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products.
    Brooks JP
    Transfusion; 2005 Oct; 45(4 Suppl):159S-71S. PubMed ID: 16181401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mass-scale red cell genotyping of blood donors: from data visualization to historical antigen labeling and donor recruitment.
    Denomme GA; Anani WQ
    Transfusion; 2019 Sep; 59(9):2768-2770. PubMed ID: 31246285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing patient safety and efficiency in transfusion therapy using formal process definitions.
    Henneman EA; Avrunin GS; Clarke LA; Osterweil LJ; Andrzejewski C; Merrigan K; Cobleigh R; Frederick K; Katz-Bassett E; Henneman PL
    Transfus Med Rev; 2007 Jan; 21(1):49-57. PubMed ID: 17174220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of the blood supply.
    Fiebig E
    Clin Orthop Relat Res; 1998 Dec; (357):6-18. PubMed ID: 9917695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Red blood cell transfusion in critically ill patients. Emerging risks and alternatives.
    Brown M; Whalen PK
    Crit Care Nurse; 2000 Dec; Suppl():1-14; quiz 15-6. PubMed ID: 11878357
    [No Abstract]   [Full Text] [Related]  

  • 31. Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation.
    Mueller MM; Seifried E
    Transfus Clin Biol; 2006 Nov; 13(5):282-5; quiz 286-9. PubMed ID: 17196864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How far shall we go in the predonation selection of blood donors to safeguard patients for blood-transfusion-related infections?
    Vox Sang; 1993; 65(1):1-9. PubMed ID: 8362510
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative analysis of national regulations concerning blood safety across Europe.
    Mascaretti L; James V; Barbara J; Cárdenas JM; Blagoevska M; Haracić M; Rossi U
    Transfus Med; 2004 Apr; 14(2):105-12. PubMed ID: 15113375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. West Nile virus transmission via organ transplantation and blood transfusion - Louisiana, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(45):1263-7. PubMed ID: 19940831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for transfusion in Norway.
    Hervig T; Flesland O; Svenningsen V; Bosnes V
    Transfus Apher Sci; 2004 Dec; 31(3):181-4. PubMed ID: 15556464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil.
    Maresch C; Schluter PJ; Wilson AD; Sleigh A
    Transfusion; 2008 Feb; 48(2):273-81. PubMed ID: 18005323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of donating multiple products in a single apheresis collection: are we expecting too much?
    Strauss RG
    J Clin Apher; 2003; 18(3):135-40. PubMed ID: 14569607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood transfusion practice].
    Marchand J; Gouëzec H
    Transfus Clin Biol; 2005 Jun; 12(2):180-5. PubMed ID: 15894498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006.
    Polizzotto MN; Wood EM; Ingham H; Keller AJ;
    Transfusion; 2008 Jan; 48(1):55-63. PubMed ID: 17894794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.